Research study Program year 2022 Source: CMS Open Payments

Acp-103-046

ClinicalTrials.gov NCT03325556

Research payments

$5,311,317

310 payments

Through program year 2022, $5,311,317 in research payments was reported against Acp-103-046, across 310 payments, paid by ACADIA Pharmaceuticals Inc.

Paid by: ACADIA Pharmaceuticals Inc
ClinicalTrials.gov: NCT03325556

By program year

4 rows

Year	Kind	Amount	Payments
2022	Research	$1,419,703	96
2021	Research	$1,528,137	65
2020	Research	$1,252,428	77
2019	Research	$1,111,049	72

Breakdown

Who paid Research payments · program years 2019–2022

ACADIA Pharmaceuticals Inc $5,311,317 310 payments

Who received the money Research payments · program years 2019–2022

Future Care Solutions LLC Organisation paid for research $1,312,597 32 payments
Mediclear Medical & Research Center INC Organisation paid for research $787,494 26 payments
Indago Research and Health Center Organisation paid for research $672,178 19 payments
Reliable Clinical Research LLC Organisation paid for research $468,885 27 payments
Premier Clinical Research Institute INC Organisation paid for research $462,595 22 payments
Novel Clinical Research LLC Organisation paid for research $333,761 16 payments
Indago Research & Health Center INC Organisation paid for research $222,840 17 payments
Raa Apex Acquisition Lcc Dba Syrentis Clinical Research Organisation paid for research $206,856 22 payments
Future Care Solution LLC Organisation paid for research $156,162 5 payments
Atp Clinical Research INC Organisation paid for research $67,604 7 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.